These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36301099)

  • 21. Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients.
    Liu L; Luo F
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):100. PubMed ID: 35345332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease.
    Emoto T; Yamashita T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata K
    J Atheroscler Thromb; 2016 Aug; 23(8):908-21. PubMed ID: 26947598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential biomarkers of acute myocardial infarction based on the composition of the blood microbiome.
    Chen R; Ye Y; Ding Y; Wan Z; Ye X; Liu J
    Clin Chim Acta; 2024 Mar; 556():117843. PubMed ID: 38387830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV.
    Trøseid M; Molinaro A; Gelpi M; Vestad B; Kofoed KF; Fuchs A; Køber L; Holm K; Benfield T; Ueland PM; Hov JR; Nielsen SD; Knudsen AD
    J Infect Dis; 2024 Mar; 229(3):898-907. PubMed ID: 38195204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease.
    Liu Z; Li J; Liu H; Tang Y; Zhan Q; Lai W; Ao L; Meng X; Ren H; Xu D; Zeng Q
    Atherosclerosis; 2019 May; 284():121-128. PubMed ID: 30897381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease.
    Lambadiari V; Kadoglou NP; Stasinos V; Maratou E; Antoniadis A; Kolokathis F; Parissis J; Hatziagelaki E; Iliodromitis EK; Dimitriadis G
    Cardiovasc Diabetol; 2014 Aug; 13():121. PubMed ID: 25142320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences and in-hospital mortality in patients undergoing percutaneous coronary interventions.
    Nowakowska-Arendt A; Grabczewska Z; Koziński M; Sukiennik A; Swiatkiewicz I; Grześk G; Radomski M; Bogdan M; Kochman W; Kubica J
    Kardiol Pol; 2008 Jun; 66(6):632-9; discussion 640-1. PubMed ID: 18626832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
    Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
    J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of gut microbiota in patients with acute myocardial infarction by 16S rRNA sequencing.
    Qian X; Liu A; Liang C; He L; Xu Z; Tang S
    Ann Transl Med; 2022 Dec; 10(24):1340. PubMed ID: 36660636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiome and microbial metabolites in acute myocardial infarction.
    Liu C; Sun Z; Shali S; Mei Z; Chang S; Mo H; Xu L; Pu Y; Guan H; Chen GC; Qi Q; Quan Z; Qi J; Yao K; Dai Y; Zheng Y; Ge J
    J Genet Genomics; 2022 Jun; 49(6):569-578. PubMed ID: 34974193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
    Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
    Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery disease is associated with an altered gut microbiome composition.
    Toya T; Corban MT; Marrietta E; Horwath IE; Lerman LO; Murray JA; Lerman A
    PLoS One; 2020; 15(1):e0227147. PubMed ID: 31995569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis.
    Fang C; Zuo K; Fu Y; Li J; Wang H; Xu L; Yang X
    Front Cardiovasc Med; 2022; 9():832092. PubMed ID: 35402559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy.
    Anastasilakis AD; Koulaxis D; Kefala N; Polyzos SA; Upadhyay J; Pagkalidou E; Economou F; Anastasilakis CD; Mantzoros CS
    Metabolism; 2017 Aug; 73():1-8. PubMed ID: 28732565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbiota and Environment in Coronary Artery Disease.
    Piccioni A; de Cunzo T; Valletta F; Covino M; Rinninella E; Raoul P; Zanza C; Mele MC; Franceschi F
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum concentration of soluble adhesive molecules in patients with different forms of coronary artery disease].
    Damnjanović G; Jelić M; Dindić B; Ilić S
    Vojnosanit Pregl; 2009 Apr; 66(4):265-70. PubMed ID: 19432291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF/MS.
    Xu X; Gao B; Guan Q; Zhang D; Ye X; Zhou L; Tong G; Li H; Zhang L; Tian J; Huang J
    J Pharm Biomed Anal; 2016 Sep; 129():34-42. PubMed ID: 27394176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of coronary disease patients at high risk for recurrent myocardial infarction by elevated plasma inactive creatine kinase B protein levels.
    Burnam MH; Crouch MA; Chew CY; Carnegie W; Hecht H; Singh BN
    Am Heart J; 1981 May; 101(5):561-9. PubMed ID: 7223596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease.
    Wolk R; Berger P; Lennon RJ; Brilakis ES; Somers VK
    Circulation; 2003 Nov; 108(18):2206-11. PubMed ID: 14557360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.